U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07321509) titled 'Digoxin After Acute Heart Failure' on Dec. 09, 2025.
Brief Summary: The DIG-DICA trial is a randomized, controlled, open-label, single-center study designed to evaluate whether adding low-dose digoxin to optimal medical therapy after an episode of acute decompensated heart failure improves patients' clinical status and quality of life. The study enrolls adults with heart failure with reduced ejection fraction (HFrEF) who have recently stabilized after hospitalization or urgent care for decompensation. The primary aim is to determine whether digoxin increases the proportion of patients who are "Alive and Well" at 180 days-defined by a...